Disease on EC 2.1.1.20 - glycine N-methyltransferase
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
adenosine kinase deficiency
Consensus recommendations for the diagnosis, treatment and follow-up of inherited methylation disorders.
adenosine kinase deficiency
S-adenosylmethionine induces mitochondrial dysfunction, permeability transition pore opening and redox imbalance in subcellular preparations of rat liver.
adenosylhomocysteinase deficiency
Inherited disorders in the conversion of methionine to homocysteine.
Atherosclerosis
Deficiency of Glycine N-methyltransferase Aggravates Atherosclerosis in Apolipoprotein E-null Mice.
Brain Neoplasms
Expression of sarcosine metabolism-related proteins according to metastatic site in breast cancer.
Breast Neoplasms
Expression of sarcosine metabolism-related proteins according to metastatic site in breast cancer.
Breast Neoplasms
Implications of differences in expression of sarcosine metabolism-related proteins according to the molecular subtype of breast cancer.
Breast Neoplasms
MAT2A Localization and Its Independently Prognostic Relevance in Breast Cancer Patients.
Carcinogenesis
A novel role of the tumor suppressor GNMT in cellular defense against DNA damage.
Carcinogenesis
Characterization of the GNMT-HectH9-PREX2 tripartite relationship in the pathogenesis of hepatocellular carcinoma.
Carcinogenesis
Gene Expression and DNA Methylation Alterations in the Glycine N-Methyltransferase Gene in Diet-Induced Nonalcoholic Fatty Liver Disease-Associated Carcinogenesis.
Carcinogenesis
Glycine N-methyltransferase deletion in mice diverts carbon flux from gluconeogenesis to pathways that utilize excess methionine cycle intermediates.
Carcinogenesis
Glycine N-methyltransferase-/- mice develop chronic hepatitis and glycogen storage disease in the liver.
Carcinogenesis
GNMT expression increases hepatic folate contents and folate-dependent methionine synthase-mediated homocysteine remethylation.
Carcinogenesis
Hepatoma Cells From Mice Deficient in Glycine N-Methyltransferase Have Increased RAS Signaling and Activation of Liver Kinase B1.
Carcinogenesis
Higher susceptibility to aflatoxin B(1)-related hepatocellular carcinoma in glycine N-methyltransferase knockout mice.
Carcinogenesis
MicroRNA-224 down-regulates Glycine N-methyltransferase gene expression in Hepatocellular Carcinoma.
Carcinogenesis
The important role of glycine N-methyltransferase in the carcinogenesis and progression of prostate cancer.
Carcinogenesis
The role of stem cells/progenitor cells in liver carcinogenesis in glycine N-methyltransferase deficient mice.
Carcinogenesis
Tumor suppressor gene glycine N-methyltransferase and its potential in liver disorders and hepatocellular carcinoma.
Carcinoma, Hepatocellular
A DNA methylation signature associated with the epigenetic repression of glycine N-methyltransferase in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
A novel role of the tumor suppressor GNMT in cellular defense against DNA damage.
Carcinoma, Hepatocellular
AAV serotype 8-mediated liver specific GNMT expression delays progression of hepatocellular carcinoma and prevents carbon tetrachloride-induced liver damage.
Carcinoma, Hepatocellular
Alteration of glycine N-methyltransferase activity in fetal, adult, and tumor tissues.
Carcinoma, Hepatocellular
Alterations of methionine metabolism in hepatocarcinogenesis: the emergent role of glycine N-methyltransferase in liver injury.
Carcinoma, Hepatocellular
Benzo(a)pyrene induced glycine N-methyltransferase messenger RNA expression in Fundulus heteroclitus embryos.
Carcinoma, Hepatocellular
Blocking sphingosine 1-phosphate receptor 2 accelerates hepatocellular carcinoma progression in a mouse model of NASH.
Carcinoma, Hepatocellular
Characterization of a glycine N-methyltransferase gene knockout mouse model for hepatocellular carcinoma: Implications of the gender disparity in liver cancer susceptibility.
Carcinoma, Hepatocellular
Characterization of reduced expression of glycine N-methyltransferase in cancerous hepatic tissues using two newly developed monoclonal antibodies.
Carcinoma, Hepatocellular
Characterization of the 5' regulatory region of the human glycine N-methyltransferase gene.
Carcinoma, Hepatocellular
Deficiency of glycine N-methyltransferase results in deterioration of cellular defense to stress in mouse liver.
Carcinoma, Hepatocellular
Dysregulated transmethylation leading to hepatocellular carcinoma compromises redox homeostasis and glucose formation.
Carcinoma, Hepatocellular
Functional Characterization of Glycine N-methyltransferase and its Interactive Protein-DEPDC6/DEPTOR in Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Genomic structure, expression, and chromosomal localization of the human glycine N-methyltransferase gene.
Carcinoma, Hepatocellular
Genotypic and phenotypic characterization of a putative tumor susceptibility gene, GNMT, in liver cancer.
Carcinoma, Hepatocellular
Glycine N-methyltransferase affects the metabolism of aflatoxin B1 and blocks its carcinogenic effect.
Carcinoma, Hepatocellular
Glycine N-methyltransferase deletion in mice diverts carbon flux from gluconeogenesis to pathways that utilize excess methionine cycle intermediates.
Carcinoma, Hepatocellular
Glycine N-methyltransferase is a favorable prognostic marker for human cholangiocarcinoma.
Carcinoma, Hepatocellular
Glycine N-methyltransferase is a mediator of cytochrome P4501A1 gene expression.
Carcinoma, Hepatocellular
Glycine-N Methyltransferase Expression in HepG2 Cells Is Involved in Methyl Group Homeostasis by Regulating Transmethylation Kinetics and DNA Methylation.
Carcinoma, Hepatocellular
GNMT expression increases hepatic folate contents and folate-dependent methionine synthase-mediated homocysteine remethylation.
Carcinoma, Hepatocellular
Haplotypes, loss of heterozygosity, and expression levels of glycine N-methyltransferase in prostate cancer.
Carcinoma, Hepatocellular
Hepatoma Cells From Mice Deficient in Glycine N-Methyltransferase Have Increased RAS Signaling and Activation of Liver Kinase B1.
Carcinoma, Hepatocellular
Higher susceptibility to aflatoxin B(1)-related hepatocellular carcinoma in glycine N-methyltransferase knockout mice.
Carcinoma, Hepatocellular
Identification of 1,2,3,4,6-Penta-O-galloyl-?-d-glucopyranoside as a Glycine N-Methyltransferase Enhancer by High-Throughput Screening of Natural Products Inhibits Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Identification of FKBP11 as a biomarker for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Induction of GNMT by 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranoside through proteasome-independent MYC downregulation in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice.
Carcinoma, Hepatocellular
MicroRNA-224 down-regulates Glycine N-methyltransferase gene expression in Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis.
Carcinoma, Hepatocellular
Rat liver cytosolic 4 S polycyclic aromatic hydrocarbon-binding protein is glycine N-methyltransferase.
Carcinoma, Hepatocellular
Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma.
Carcinoma, Hepatocellular
Retinoic acid and glucocorticoid treatment induce hepatic glycine N-methyltransferase and lower plasma homocysteine concentrations in rats and rat hepatoma cells.
Carcinoma, Hepatocellular
Signature molecules expressed differentially in a liver disease stage-specific manner by HIV-1 and HCV co-infection.
Carcinoma, Hepatocellular
Targeted and untargeted metabolomics provide insight into the consequences of glycine-N-methyltransferase deficiency including the novel finding of defective immune function.
Carcinoma, Hepatocellular
TRAIL-producing NK cells contribute to liver injury and related fibrogenesis in the context of GNMT deficiency.
Carcinoma, Hepatocellular
Tumor suppressor gene glycine N-methyltransferase and its potential in liver disorders and hepatocellular carcinoma.
Cholangiocarcinoma
Glycine N-methyltransferase is a favorable prognostic marker for human cholangiocarcinoma.
Cholestasis
MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis.
Cleft Lip
Common polymorphism in the glycine N-methyltransferase gene as a novel risk factor for cleft lip with or without cleft palate.
Cleft Palate
Common polymorphism in the glycine N-methyltransferase gene as a novel risk factor for cleft lip with or without cleft palate.
Colitis, Ulcerative
Role of glycine N-methyltransferase in experimental ulcerative colitis.
Diabetes Mellitus
Glycine N-methyltransferase deficiency in female mice impairs insulin signaling and promotes gluconeogenesis by modulating the PI3K/Akt pathway in the liver.
Diabetes Mellitus, Type 2
Glycine N-methyltransferase deficiency in female mice impairs insulin signaling and promotes gluconeogenesis by modulating the PI3K/Akt pathway in the liver.
Diabetic Nephropathies
Carnosine alleviates diabetic nephropathy by targeting GNMT, a key enzyme mediating renal inflammation and fibrosis.
Dysplastic Nevus Syndrome
Promoter CpG Island Hypermethylation in Dysplastic Nevus and Melanoma: CLDN11 as an Epigenetic Biomarker for Malignancy.
Encephalomyelitis
Role of Glycine N-methyltransferase in The Regulation of T Cell Responses in Experimental Autoimmune Encephalomyelitis.
Encephalomyelitis, Autoimmune, Experimental
Role of Glycine N-methyltransferase in The Regulation of T Cell Responses in Experimental Autoimmune Encephalomyelitis.
Fatty Liver
Dysregulated transmethylation leading to hepatocellular carcinoma compromises redox homeostasis and glucose formation.
Fatty Liver
Fatty liver and fibrosis in glycine N-methyltransferase knockout mice is prevented by nicotinamide.
Fatty Liver
Glycine N-methyltransferase deficiency in female mice impairs insulin signaling and promotes gluconeogenesis by modulating the PI3K/Akt pathway in the liver.
Fatty Liver
Methionine and S-adenosylmethionine levels are critical regulators of PP2A activity modulating lipophagy during steatosis.
Fatty Liver
miR-873-5p targets mitochondrial GNMT-Complex II interface contributing to non-alcoholic fatty liver disease.
Fatty Liver
Total liver phosphatidylcholine content associates with non-alcoholic steatohepatitis and glycine N-methyltransferase expression.
Fatty Liver
TRAIL-producing NK cells contribute to liver injury and related fibrogenesis in the context of GNMT deficiency.
glycine n-methyltransferase deficiency
Characterization of reduced expression of glycine N-methyltransferase in cancerous hepatic tissues using two newly developed monoclonal antibodies.
glycine n-methyltransferase deficiency
Deficiency of glycine N-methyltransferase results in deterioration of cellular defense to stress in mouse liver.
glycine n-methyltransferase deficiency
Glycine N -methyltransferase deficiency: a new patient with a novel mutation.
glycine n-methyltransferase deficiency
Glycine N-methyltransferase Deficiency Affects Niemann-Pick Type C2 Protein Stability and Regulates Hepatic Cholesterol Homeostasis.
glycine n-methyltransferase deficiency
Glycine N-methyltransferase deficiency in female mice impairs insulin signaling and promotes gluconeogenesis by modulating the PI3K/Akt pathway in the liver.
glycine n-methyltransferase deficiency
Glycine N-Methyltransferase Deficiency: A Member of Dysmethylating Liver Disorders?
glycine n-methyltransferase deficiency
Glycine N-methyltransferase deficiency: a novel inborn error causing persistent isolated hypermethioninaemia.
glycine n-methyltransferase deficiency
Glycine N-methyltransferase-/- mice develop chronic hepatitis and glycogen storage disease in the liver.
glycine n-methyltransferase deficiency
Inherited disorders in the conversion of methionine to homocysteine.
glycine n-methyltransferase deficiency
Methionine and S-adenosylmethionine levels are critical regulators of PP2A activity modulating lipophagy during steatosis.
glycine n-methyltransferase deficiency
Methyl balance and transmethylation fluxes in humans.
glycine n-methyltransferase deficiency
MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis.
glycine n-methyltransferase deficiency
Role of Glycine N-methyltransferase in The Regulation of T Cell Responses in Experimental Autoimmune Encephalomyelitis.
glycine n-methyltransferase deficiency
The multi-functional roles of GNMT in toxicology and cancer.
glycine n-methyltransferase deficiency
TRAIL-producing NK cells contribute to liver injury and related fibrogenesis in the context of GNMT deficiency.
glycine n-methyltransferase deficiency
Tumor suppressor gene glycine N-methyltransferase and its potential in liver disorders and hepatocellular carcinoma.
guanidinoacetate n-methyltransferase deficiency
Methyl balance and transmethylation fluxes in humans.
Heart Defects, Congenital
Maternal and infant genetic variants, maternal periconceptional use of selective serotonin reuptake inhibitors, and risk of congenital heart defects in offspring: population based study.
Hepatitis, Chronic
Deficiency of glycine N-methyltransferase results in deterioration of cellular defense to stress in mouse liver.
Hepatitis, Chronic
Glycine N-methyltransferase affects the metabolism of aflatoxin B1 and blocks its carcinogenic effect.
Hepatitis, Chronic
Glycine N-methyltransferase Deficiency Affects Niemann-Pick Type C2 Protein Stability and Regulates Hepatic Cholesterol Homeostasis.
Hepatitis, Chronic
Glycine N-methyltransferase deficiency in female mice impairs insulin signaling and promotes gluconeogenesis by modulating the PI3K/Akt pathway in the liver.
Hepatoblastoma
Characterization of reduced expression of glycine N-methyltransferase in cancerous hepatic tissues using two newly developed monoclonal antibodies.
Hepatomegaly
Characterization of reduced expression of glycine N-methyltransferase in cancerous hepatic tissues using two newly developed monoclonal antibodies.
Hyperlipidemias
Deficiency of Glycine N-methyltransferase Aggravates Atherosclerosis in Apolipoprotein E-null Mice.
Infections
Enhanced expression of glycine N-methyltransferase by adenovirus-mediated gene transfer in CNS culture is neuroprotective.
Infections
Global and Complement Gene-Specific DNA Methylation in Grass Carp after Grass Carp Reovirus (GCRV) Infection.
Infections
Glycine N-methyltransferase tumor susceptibility gene in the benzo(a)pyrene-detoxification pathway.
Insulin Resistance
Glycine N-methyltransferase deficiency in female mice impairs insulin signaling and promotes gluconeogenesis by modulating the PI3K/Akt pathway in the liver.
Liver Cirrhosis
AAV serotype 8-mediated liver specific GNMT expression delays progression of hepatocellular carcinoma and prevents carbon tetrachloride-induced liver damage.
Liver Cirrhosis
MicroRNA-224 down-regulates Glycine N-methyltransferase gene expression in Hepatocellular Carcinoma.
Liver Cirrhosis
MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis.
Liver Cirrhosis
Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma.
Liver Diseases
AAV serotype 8-mediated liver specific GNMT expression delays progression of hepatocellular carcinoma and prevents carbon tetrachloride-induced liver damage.
Liver Diseases
Deficiency of Glycine N-methyltransferase Aggravates Atherosclerosis in Apolipoprotein E-null Mice.
Liver Diseases
Fatty liver and fibrosis in glycine N-methyltransferase knockout mice is prevented by nicotinamide.
Liver Diseases
Gestation under chronic constant light leads to extensive gene expression changes in the fetal rat liver.
Liver Diseases
Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice.
Liver Diseases
Methionine and S-adenosylmethionine levels are critical regulators of PP2A activity modulating lipophagy during steatosis.
Liver Diseases
S-adenosylmethionine induces mitochondrial dysfunction, permeability transition pore opening and redox imbalance in subcellular preparations of rat liver.
Liver Diseases
Signature molecules expressed differentially in a liver disease stage-specific manner by HIV-1 and HCV co-infection.
Liver Diseases
TRAIL-producing NK cells contribute to liver injury and related fibrogenesis in the context of GNMT deficiency.
Liver Diseases
Tumor suppressor gene glycine N-methyltransferase and its potential in liver disorders and hepatocellular carcinoma.
Liver Neoplasms
Benzo[a]pyrene and glycine N-methyltransferse interactions: gene expression profiles of the liver detoxification pathway.
Liver Neoplasms
Characterization of a glycine N-methyltransferase gene knockout mouse model for hepatocellular carcinoma: Implications of the gender disparity in liver cancer susceptibility.
Liver Neoplasms
Characterization of glycine-N-methyltransferase-gene expression in human hepatocellular carcinoma.
Liver Neoplasms
Discovery of an Orally Efficacious MYC Inhibitor for Liver Cancer Using a GNMT-Based High-Throughput Screening System and Structure-Activity Relationship Analysis.
Liver Neoplasms
Gene Expression and DNA Methylation Alterations in the Glycine N-Methyltransferase Gene in Diet-Induced Nonalcoholic Fatty Liver Disease-Associated Carcinogenesis.
Liver Neoplasms
Genotypic and phenotypic characterization of a putative tumor susceptibility gene, GNMT, in liver cancer.
Liver Neoplasms
Glycine N-methyltransferase deficiency in female mice impairs insulin signaling and promotes gluconeogenesis by modulating the PI3K/Akt pathway in the liver.
Liver Neoplasms
Glycine N-methyltransferase tumor susceptibility gene in the benzo(a)pyrene-detoxification pathway.
Liver Neoplasms
GNMT negatively regulates MAPK pathway and suppresses the growth and metastasis of hepatocellular cancer cells.
Liver Neoplasms
Higher susceptibility to aflatoxin B(1)-related hepatocellular carcinoma in glycine N-methyltransferase knockout mice.
Liver Neoplasms
Identification of 1,2,3,4,6-Penta-O-galloyl-?-d-glucopyranoside as a Glycine N-Methyltransferase Enhancer by High-Throughput Screening of Natural Products Inhibits Hepatocellular Carcinoma.
Liver Neoplasms
Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice.
Malaria
Possible selection of host folate pathway gene polymorphisms in patients with malaria from a malaria endemic region in North East India.
Melanoma
Promoter CpG Island Hypermethylation in Dysplastic Nevus and Melanoma: CLDN11 as an Epigenetic Biomarker for Malignancy.
Metabolic Syndrome
Glycine N-methyltransferase deficiency in female mice impairs insulin signaling and promotes gluconeogenesis by modulating the PI3K/Akt pathway in the liver.
Metabolic Syndrome
Loss of Glycine N-Methyltransferase Associates with Angiopoietin-Like Protein 8 Expression in High Fat-Diet-Fed Mice.
Neoplasm Metastasis
Expression of sarcosine metabolism-related proteins according to metastatic site in breast cancer.
Neoplasm Metastasis
GNMT negatively regulates MAPK pathway and suppresses the growth and metastasis of hepatocellular cancer cells.
Neoplasms
A DNA methylation signature associated with the epigenetic repression of glycine N-methyltransferase in human hepatocellular carcinoma.
Neoplasms
A novel role of the tumor suppressor GNMT in cellular defense against DNA damage.
Neoplasms
A novel tumor suppressor function of glycine N-methyltransferase is independent of its catalytic activity but requires nuclear localization.
Neoplasms
AAV serotype 8-mediated liver specific GNMT expression delays progression of hepatocellular carcinoma and prevents carbon tetrachloride-induced liver damage.
Neoplasms
Alteration of glycine N-methyltransferase activity in fetal, adult, and tumor tissues.
Neoplasms
Alterations of methionine metabolism in hepatocarcinogenesis: the emergent role of glycine N-methyltransferase in liver injury.
Neoplasms
Androgen Response Element of the Glycine N-Methyltransferase Gene is Located in the Coding Region of its First Exon.
Neoplasms
Characterization of a glycine N-methyltransferase gene knockout mouse model for hepatocellular carcinoma: Implications of the gender disparity in liver cancer susceptibility.
Neoplasms
Characterization of the 5' regulatory region of the human glycine N-methyltransferase gene.
Neoplasms
Functional Characterization of Glycine N-methyltransferase and its Interactive Protein-DEPDC6/DEPTOR in Hepatocellular Carcinoma.
Neoplasms
Genetic polymorphisms of the glycine N-methyltransferase and prostate cancer risk in the health professionals follow-up study.
Neoplasms
Genotypic and phenotypic characterization of a putative tumor susceptibility gene, GNMT, in liver cancer.
Neoplasms
Glycine N-methyltransferase affects the metabolism of aflatoxin B1 and blocks its carcinogenic effect.
Neoplasms
Glycine N-methyltransferase is a favorable prognostic marker for human cholangiocarcinoma.
Neoplasms
Glycine N-methyltransferase tumor susceptibility gene in the benzo(a)pyrene-detoxification pathway.
Neoplasms
Glycine-N Methyltransferase Expression in HepG2 Cells Is Involved in Methyl Group Homeostasis by Regulating Transmethylation Kinetics and DNA Methylation.
Neoplasms
Haplotypes, loss of heterozygosity, and expression levels of glycine N-methyltransferase in prostate cancer.
Neoplasms
Identification of 1,2,3,4,6-Penta-O-galloyl-?-d-glucopyranoside as a Glycine N-Methyltransferase Enhancer by High-Throughput Screening of Natural Products Inhibits Hepatocellular Carcinoma.
Neoplasms
MicroRNA-224 down-regulates Glycine N-methyltransferase gene expression in Hepatocellular Carcinoma.
Neoplasms
Regulation of Folate-Mediated One-Carbon Metabolism by Glycine N-Methyltransferase (GNMT) and Methylenetetrahydrofolate Reductase (MTHFR).
Neoplasms
Role of Glycine N-methyltransferase in The Regulation of T Cell Responses in Experimental Autoimmune Encephalomyelitis.
Neoplasms
Tumor suppressor gene glycine N-methyltransferase and its potential in liver disorders and hepatocellular carcinoma.
Neoplasms
Utilizing proteomic approach to identify nuclear translocation related serine kinase phosphorylation site of GNMT as downstream effector for benzo[a]pyrene.
Non-alcoholic Fatty Liver Disease
Gene Expression and DNA Methylation Alterations in the Glycine N-Methyltransferase Gene in Diet-Induced Nonalcoholic Fatty Liver Disease-Associated Carcinogenesis.
Non-alcoholic Fatty Liver Disease
Gestation under chronic constant light leads to extensive gene expression changes in the fetal rat liver.
Non-alcoholic Fatty Liver Disease
Glycine N-methyltransferase Deficiency Affects Niemann-Pick Type C2 Protein Stability and Regulates Hepatic Cholesterol Homeostasis.
Non-alcoholic Fatty Liver Disease
Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Methionine and S-adenosylmethionine levels are critical regulators of PP2A activity modulating lipophagy during steatosis.
Non-alcoholic Fatty Liver Disease
miR-873-5p targets mitochondrial GNMT-Complex II interface contributing to non-alcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Proteomic analysis of liver mitochondria of apolipoprotein E knockout mice treated with metformin.
Pancreatic Neoplasms
The Case for GNMT as a Biomarker and a Therapeutic Target in Pancreatic Cancer.
Pellagra
Fatty liver and fibrosis in glycine N-methyltransferase knockout mice is prevented by nicotinamide.
Prostatic Hyperplasia
Haplotypes, loss of heterozygosity, and expression levels of glycine N-methyltransferase in prostate cancer.
Prostatic Neoplasms
Characterisation of the androgen regulation of glycine N-methyltransferase in prostate cancer cells.
Prostatic Neoplasms
Characterization of the 5' regulatory region of the human glycine N-methyltransferase gene.
Prostatic Neoplasms
Genetic polymorphisms of the glycine N-methyltransferase and prostate cancer risk in the health professionals follow-up study.
Prostatic Neoplasms
Haplotypes, loss of heterozygosity, and expression levels of glycine N-methyltransferase in prostate cancer.
Prostatic Neoplasms
Modulation of long noncoding RNAs by risk SNPs underlying genetic predispositions to prostate cancer.
Prostatic Neoplasms
Strong cis-acting expression quantitative trait loci for the genes encoding SNHG5 and PEX6.
Prostatic Neoplasms
The important role of glycine N-methyltransferase in the carcinogenesis and progression of prostate cancer.
Psoriasis
Polymorphisms in GNMT and DNMT3b are associated with methotrexate treatment outcome in plaque psoriasis.
Sarcoma, Avian
Glycine N-methyltransferase is an example of functional diversity. Role as a polycyclic aromatic hydrocarbon-binding receptor.
Squamous Cell Carcinoma of Head and Neck
Identification of novel methylation markers in HPV-associated oropharyngeal cancer: genome-wide discovery, tissue verification and validation testing in ctDNA.
html completed